These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38264609)

  • 21. A novel ophthalmic latanoprost 0.005% nanoemulsion: a cytotoxicity study.
    Tau J; Passerini MS; Del Papa M; Aguilar A; Berra A
    Graefes Arch Clin Exp Ophthalmol; 2022 Jun; 260(6):1941-1946. PubMed ID: 35015115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost.
    Wu JH; Wang TH; Huang JY; Su CC
    J Ocul Pharmacol Ther; 2021 Dec; 37(10):556-564. PubMed ID: 34610257
    [No Abstract]   [Full Text] [Related]  

  • 23. Benzalkonium Chloride-Induced Corneal Epithelial Injury in Rabbit Reduced by Rebamipide.
    Fukuda M; Takeda N; Ishida H; Seki Y; Shibata N; Takahashi N; Sugiyama K; Kubo E; Sasaki H
    J Ocul Pharmacol Ther; 2022; 38(1):85-91. PubMed ID: 34936495
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparative study of a preservative-free latanoprost cationic emulsion (Catioprost) and a BAK-preserved latanoprost solution in animal models.
    Daull P; Buggage R; Lambert G; Faure MO; Serle J; Wang RF; Garrigue JS
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):515-23. PubMed ID: 22671995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride.
    Liang H; Baudouin C; Pauly A; Brignole-Baudouin F
    Br J Ophthalmol; 2008 Sep; 92(9):1275-82. PubMed ID: 18723745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human lens epithelial cell damage and stimulation of their secretion of chemical mediators by benzalkonium chloride rather than latanoprost and timolol.
    Goto Y; Ibaraki N; Miyake K
    Arch Ophthalmol; 2003 Jun; 121(6):835-9. PubMed ID: 12796255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triacylglycerol lipidome from human meibomian gland epithelial cells: Description, response to culture conditions, and perspective on function.
    Ziemanski JF; Wilson L; Barnes S; Nichols KK
    Exp Eye Res; 2021 Jun; 207():108573. PubMed ID: 33848521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost.
    Katz G; Springs CL; Craven ER; Montecchi-Palmer M
    Clin Ophthalmol; 2010 Nov; 4():1253-61. PubMed ID: 21151330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicity of cosmetic preservatives on human ocular surface and adnexal cells.
    Chen X; Sullivan DA; Sullivan AG; Kam WR; Liu Y
    Exp Eye Res; 2018 May; 170():188-197. PubMed ID: 29486163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of glaucoma medications and preservatives on cultured human trabecular meshwork and non-pigmented ciliary epithelial cell lines.
    Ammar DA; Kahook MY
    Br J Ophthalmol; 2011 Oct; 95(10):1466-9. PubMed ID: 21602479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninferiority of Preservative-free Versus BAK-preserved Latanoprost-timolol Fixed Combination Eye Drops in Patients With Open-angle Glaucoma or Ocular Hypertension.
    Aptel F; Pfeiffer N; Schmickler S; Clarke J; Lavín-Dapena C; Moreno-Montañés J; Żarnowski T; Csutak A; Jugaste T; Volksone L; Astakhov YS; Coupier L; Nordmann JP; Stalmans I;
    J Glaucoma; 2019 Jun; 28(6):498-506. PubMed ID: 31166287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The preservative polyquaternium-1 increases cytoxicity and NF-kappaB linked inflammation in human corneal epithelial cells.
    Paimela T; Ryhänen T; Kauppinen A; Marttila L; Salminen A; Kaarniranta K
    Mol Vis; 2012; 18():1189-96. PubMed ID: 22605930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiochemical Properties and Cytotoxicity of a Benzalkonium Chloride-Free, Micellar Emulsion Ophthalmic Formulation of Latanoprost.
    Halder A; Khopade AJ
    Clin Ophthalmol; 2020; 14():3057-3064. PubMed ID: 33116357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of PPAR-γ and RXR-α on mouse meibomian gland epithelial cells during inflammation induced by latanoprost.
    Jiang XY; Yang PS; Xiao O; Yu K; Wang SY; Yang SJ; Zhou SY
    Exp Eye Res; 2022 Nov; 224():109251. PubMed ID: 36150542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells.
    Datta S; Baudouin C; Brignole-Baudouin F; Denoyer A; Cortopassi GA
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2406-2412. PubMed ID: 28444329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo evaluation of a preservative-free cationic emulsion of latanoprost in corneal wound healing models.
    Liang H; Baudouin C; Daull P; Garrigue JS; Buggage R; Brignole-Baudouin F
    Cornea; 2012 Nov; 31(11):1319-29. PubMed ID: 22929154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost.
    García-Feijoo J; Muñoz-Negrete FJ; Hubatsch DA; Rossi GC
    Clin Ophthalmol; 2016; 10():2085-2091. PubMed ID: 27799736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of corneal epithelial integrity after acute exposure to ocular hypotensive agents preserved with and without benzalkonium chloride.
    Whitson JT; Cavanagh HD; Lakshman N; Petroll WM
    Adv Ther; 2006; 23(5):663-71. PubMed ID: 17142200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noninferiority Study Comparing Latanoprost 0.005% Without Versus With Benzalkonium Chloride in Open-Angle Glaucoma or Ocular Hypertension.
    Wirta D; Malhotra R; Peace J; Shen Lee B; Mitchell B; Sall K; McMenemy M
    Eye Contact Lens; 2022 Apr; 48(4):149-154. PubMed ID: 35296626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost.
    Aihara M; Otani S; Kozaki J; Unoki K; Takeuchi M; Minami K; Miyata K
    J Glaucoma; 2012 Jan; 21(1):60-4. PubMed ID: 21278589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.